Press Releases
BridgeBio Awards Grant to Rare Genomics Institute to Help Rare Disease Patients
The Rare Genomics Institute (RG) today announced it has received a grant from BridgeBio Pharma, a clinical-stage biopharmaceutical company founded to discover, create, test and deliver meaningful medicines for patients with genetic diseases and cancers with clear genetic drivers. RG, a non-profit that makes cutting-edge research technologies and experts accessible to rare disease patients, will use the funds to expand its programs supporting rare disease patients.
Rare Genomics Institute BeHEARD Challenge Awards 21 Rare Disease Grants
Washington, D.C. August 6, 2020. The Rare Genomics Institute (RG) is delighted to announce the winners of the 2019-2020 BeHEARD (Helping Empower and Accelerate Research Discoveries) Rare Disease Science Challenge, a global competition that offers rare disease researchers, who traditionally have difficulty attracting funding, grants of the latest life science innovations and technologies. This unique biotechnology contest allows companies to contribute their technology to make a difference for the rare disease community.